Valera Pharmaceuticals Reports 2006 Financial Results
CRANBURY, NJ -- (MARKET WIRE) -- February 22, 2007 -- Valera Pharmaceuticals (NASDAQ: VLRX), a specialty pharmaceutical company focused on the development, acquisition and commercialization of products for the urology and endocrinology markets, today announced financial results for the three months and full year ended December 31, 2006.